Stocks News

LAST PRICE
37.1850
TODAY'S CHANGE (%)
Trending Up1.0150 (2.8062%)

Bid / Lots
37.1100/ 3
Ask / Lots
37.2500/ 7
Open / Previous Close
36.2300 / 36.1700
Day Range
Low 36.0100
High 37.2520
52 Week Range
Low 18.9400
High 39.0450
Volume
45,801
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 20, 2024
- AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 8:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: ATRC
  
  AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
  MASON, Ohio--(BUSINESS WIRE)--November 20, 2024--
  AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 36(th) Annual Healthcare Conference.
Nov 7, 2024
- AtriCure to Participate in the Stifel 2024 Healthcare Conference, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ATRC
  
  AtriCure to Participate in the Stifel 2024 Healthcare Conference
  MASON, Ohio--(BUSINESS WIRE)--November 07, 2024--
  AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Stifel 2024 Healthcare Conference.
Oct 30, 2024
- DJ AtriCure Is Maintained at Buy by Canaccord Genuity, from 1:35PM ET on Wednesday Oct 30, 2024 by Dow Jones
  1:35PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ATRC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ATRC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 13:35 ET (17:35 GMT)
- DJ AtriCure Is Maintained at Outperform by Oppenheimer, from 12:00PM ET on Wednesday Oct 30, 2024 by Dow Jones
  12:00PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ATRC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ATRC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 12:00 ET (16:00 GMT)
- DJ AtriCure Is Maintained at Overweight by JP Morgan, from 11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: ATRC
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ATRC/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 30, 2024 11:30 ET (15:30 GMT)

Nov 27, 2024
- DJ Trump's Unusual Pick for NIH Director May Be a Win for These Stocks -- Barrons.com, from 2:26PM ET on Wednesday Nov 27, 2024 by Dow Jones
  2:26PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: ILMN, TXG
- Novocure to Participate in Upcoming Investor Conferences, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: NVCR
Nov 25, 2024
- STAAR Surgical to Participate in BTIG Ophthalmology Day, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: STAA
Nov 21, 2024
- DJ Novocure Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 1:08PM ET on Thursday Nov 21, 2024 by Dow Jones
  1:08PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: NVCR
- NovoCure Gets FDA Nod for Updated Optune Gio Arrays, from 8:37AM ET on Thursday Nov 21, 2024 by MT Newswires
  8:37AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: NVCR
- Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma, from 7:05AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:05AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: NVCR
- FDA Approves Novocure's Innovative HFE Transducer Arrays for Use With Optune Gio(R) for Glioblastoma, from 7:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: NVCR
Nov 20, 2024
- DJ If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer -- Barrons.com, from 3:29PM ET on Wednesday Nov 20, 2024 by Dow Jones
  3:29PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: ILMN, TXG
Nov 15, 2024
- RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing, from 3:35AM ET on Friday Nov 15, 2024 by MT Newswires
  3:35AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: RXST
Nov 13, 2024
- STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024), from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: STAA

AtriCure Inc
NASDAQ:ATRCUnited States

Search Criteria

Nov 20, 2024

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 8:00AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 7, 2024

AtriCure to Participate in the Stifel 2024 Healthcare Conference, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Oct 30, 2024

DJ AtriCure Is Maintained at Buy by Canaccord Genuity, from 1:35PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ AtriCure Is Maintained at Outperform by Oppenheimer, from 12:00PM ET on Wednesday Oct 30, 2024 by Dow Jones

DJ AtriCure Is Maintained at Overweight by JP Morgan, from 11:30AM ET on Wednesday Oct 30, 2024 by Dow Jones

Peers Headlines

Nov 27, 2024

DJ Trump's Unusual Pick for NIH Director May Be a Win for These Stocks -- Barrons.com, from 2:26PM ET on Wednesday Nov 27, 2024 by Dow Jones

Novocure to Participate in Upcoming Investor Conferences, from 7:00AM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 25, 2024

STAAR Surgical to Participate in BTIG Ophthalmology Day, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 21, 2024

DJ Novocure Price Target Maintained With a $30.00/Share by HC Wainwright & Co., from 1:08PM ET on Thursday Nov 21, 2024 by Dow Jones

NovoCure Gets FDA Nod for Updated Optune Gio Arrays, from 8:37AM ET on Thursday Nov 21, 2024 by MT Newswires

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma, from 7:05AM ET on Thursday Nov 21, 2024 by Dow Jones

FDA Approves Novocure's Innovative HFE Transducer Arrays for Use With Optune Gio(R) for Glioblastoma, from 7:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer -- Barrons.com, from 3:29PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 15, 2024

RxSight Insider Bought Shares Worth $1,014,570, According to a Recent SEC Filing, from 3:35AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 13, 2024

STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024), from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones